Zacks Investment Research on MSN
Here's why you should retain Inogen stock in your portfolio for now
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen ...
Inogen (NASDAQ:INGN) reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer ...
Zacks Investment Research on MSN
Inogen Q2 earnings beat estimates, sales rise Y/Y, 2026 view cut
Inogen, Inc. INGN reported breakeven earnings for second-quarter 2026, compared to the year-ago period’s adjusted loss of 2 cents per share. GAAP loss per share of 14 cents, narrower than the year-ago ...
Inogen’s latest earnings call struck an optimistic tone, highlighting a company in the midst of a strategic turnaround. Management emphasized rising volumes, improving profitability metrics and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results